Shares of Johnson & Johnson (NYS:JNJ) inched 0.26% higher to $163.36 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index (S&P:SPX) rising 2.07% to 4,686.75 and the Dow Jones Industrial Average (DOW:DJIA) rising 1.40% to 35,719.43. This was the stock's third consecutive day of gains. Johnson & Johnson closed $16.56 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. (OTC:RHHVF) fell 0.03% to $395.00, Merck & Co. Inc. (NYS:MRK) fell 1.55% to $72.28, and Pfizer Inc. (NYS:PFE) rose 0.47% to $51.72. Trading volume (8.3 M) eclipsed its 50-day average volume of 7.3 M.